Camelid heavy-chain antibody variable domains (V H Hs) are emerging as potential antimicrobial reagents. We have engineered a previously isolated V H H (FlagV1M), which binds Campylobacter jejuni flagella, for greater thermal and proteolytic stability. Mutants of FlagV1M were obtained from an error-prone polymerase chain reaction library that was panned in the presence of gastrointestinal (GI) proteases. Additional FlagV1M mutants were obtained through disulfide-bond engineering. Each approach produced V H Hs with enhanced thermal stability and protease resistance. When the beneficial mutations from both approaches were combined, a hyperstabilized V H H was created with superior stability. The hyperstabilized V H H bound C. jejuni flagella with wild-type affinity and was capable of potently inhibiting C. jejuni motility in assays performed after sequential digestion with three major GI proteases, demonstrating the remarkable stability imparted to the V H H by combining our engineering approaches.
Introduction
Campylobacter jejuni is a non-spore forming gram-negative bacterium and one of the most common food-borne pathogens in humans (Man, 2011) . Infected individuals suffer from symptoms ranging from acute diarrhea to severe neurological disorders such as Guillain-Barré syndrome, reactive arthritis and inflammatory bowel disease (Altekruse et al., 1999; Hughes et al., 1999; Willison and O'Hanlon, 1999; Humphrey et al., 2007; Man, 2011) . Strategies to control or eliminate Campylobacter prevalence in poultry, particularly in chickens, are expected to improve poultry product safety and reduce the incidence of Campylobacter-induced gastroenteritis in humans. We recently illustrated a reduction-at-source approach to address the problem by orally administering C. jejuni-specific V H H pentabodies to chickens, reducing their C. jejuni bacterial load by two to three orders of magnitude (Riazi et al., 2013) . While our approach was successful, we believe that the isolation or engineering of more robust heavy-chain antibody variable domains (V H Hs) with greater gastrointestinal (GI) tract stability would eventually lead to a more efficacious strategy to control C. jejuni infections.
Stability is a key determinant of therapeutic antibody efficacy and strategies to increase antibody stability without compromising specificity and target binding affinity are desirable. For oral immunotherapeutics to succeed in the GI tract, they must resist proteolytic digestion. Monoclonal antibodies and larger antibody fragments (i.e. Fabs, scFvs) have shown limited success in the GI tract (Reilly et al., 1997; Singh et al., 2008; Hussack et al., 2011) . Single-domain antibodies, particularly V H Hs from Camelidae, have the potential for oral immunotherapeutic development due to their high intrinsic stability and their amenability to screening, selection and engineering. Even so, orally delivered V H Hs still require considerable stabilization as demonstrated by the significant level of V H H degradation in the stomach of pigs (Harmsen et al., 2006) . A number of options exist to increase thermal, chemical and proteolytic stability of antibody fragments. These approaches include error-prone polymerase chain reaction (PCR) (Leung et al., 1989; Daugherty et al., 2000) , DNA shuffling/random mutagenesis (Harmsen et al., 2006) , site-directed mutagenesis (Wörn and Plückthun, 1998) , phage library screening under selection pressures such as heat, acidic pH and proteases (Jespers et al., 2004; Famm et al., 2008; Dudgeon et al., 2012) . Specific mutations introducing disulfide bonds have also been used to increase antibody stability (Young et al., 1995; Hagihara et al., 2007; Saerens et al., 2008; Hussack et al., 2011 Hussack et al., , 2012 Kim et al., 2012 Kim et al., , 2013 .
Here, our aim was to improve the biophysical properties of a C. jejuni flagella-binding V H H (Riazi et al., 2013) through two different approaches: by panning an error-prone PCR library in the presence of the major GI tract proteases and by disulfide-bond engineering. On their own, both mutations produced variants that were more stable compared with the parent V H H. When the beneficial mutations were combined, a hyperstabilized V H H with superior biophysical properties was produced; it retained function in terms of binding C. jejuni flagella and potently reduced C. jejuni motility in vitro.
Materials and methods

Construction of the mutant V1 library by error-prone PCR
The vector pMED1 was first modified in order to remove tag sequences which were prone to protease digestion (data not shown). The new vector is named pMED6. For error-prone PCR, 10 ng of DNA coding for V H H 'FlagV1M' (hereafter referred to as 'V1'), a V H H specific to C. jejuni flagella (Riazi et al., 2013) , was used as the initial template and amplified in a 50-ml reaction using a random mutagenesis PCR kit (GeneMorph II Random Mutagenesis kit, Stratagene, Mississauga, ON, Canada) and primers MJ7BACK and MJFOR 11 (Table I) for 30 cycles  (958C, 30 s; 558C, 30 s; 728C, 60 s) followed by a 10 min extension at 728C. The PCR products ( 500 bp in length) were purified with a QIAquick PCR purification kit (Qiagen, Mississauga, ON, Canada), digested with SfiI for 6 h at 508C (New England BioLabs, Pickering, ON, Canada) and re-purified using the same kit. Two hundred micrograms of pMED6 vector were also digested overnight at 508C followed by PstI/XhoI digestion for 2 h. The digested vector was purified with a QIAquick PCR purification kit (Qiagen) and the DNA was eluted in sterile distilled H 2 O (Arbabi- Ghahroudi et al., 2009a) . Forty-five micrograms of digested V H H fragments were ligated with 150 mg of SfiI-digested pMED6 phagemid vector (3 : 1 molar ratio, respectively) (Arbabi-Ghahroudi et al., 2009a) using a LigaFast Rapid DNA ligation system and its protocol (Promega, Madison, WI, USA). The ligated material was transformed into commercial electrocompetent Escherichia coli TG1 cells (Stratagene) as described previously (Arbabi-Ghahroudi et al., 2009a ) and a library size of 2 Â 10 9 transformants was obtained. The V H H fragments from 30 colonies were PCR-amplified and sequenced to analyze the complexity of the library. The library was grown for 3-4 h at 378C, 250 rpm in 2xYT/ampicillin supplemented with glucose (2% w/v). The bacterial cells were pelleted, resuspended in the same medium, and stored as glycerol stocks at 2808C as described previously (Arbabi-Ghahroudi et al., 2009a) .
Protease panning of the V1 error-prone PCR library
Panning experiments were essentially performed as described previously (Arbabi-Ghahroudi et al., 1997 , 2009a , except that rescued and amplified phage from the initial library and each round of panning were pre-treated with chicken GI tract fluid (Loc Carrillo et al., 2005) as well as pepsin, chymotrypsin and trypsin proteases. Three phage aliquots (125 ml each; 1 Â 10 12 phage particles) were prepared in 1 mM Tris -HCl buffer, pH 7.8. To the first phage aliquot, 12.5-ml GI tract chicken protease extract (diluted 1 in 10 in phosphate buffered saline, PBS) was added and incubated for 2 h at 378C. The second phage aliquot was incubated with an equimolar mixture of chymotrypsin/trypsin (Roche, Laval, QC, Canada) (2.5 mM of each protease in Round 1, 7.5 mM in Round 2 and 10 mM in Rounds 3 and 4; final concentration) in 1 mM HCl plus 20 mM CaCl 2 and incubated for 15 min in Round 1, 45 min in Round 2 and 60 min in Rounds 3 and 4. To the third phage aliquot, different concentrations of pepsin (Roche) were prepared in PBS and added along with 1/10 volume of 100 mM HCl, pH 2.0, to the 125 ml phage aliquot (2.5 mM in Round 1, 7.5 mM in Round 2 and 10 mM in Rounds 3 and 4; final concentrations). The protease reactions were stopped either by adding 12.5 ml of protease inhibitor cocktail (Roche) for chicken protease and trypsin/chymotrypsin or by adding 0.5 volume of 1 M Tris -HCl, pH 7.5, for pepsin. The proteasetreated phage aliquots were mixed and used for panning. A total of four rounds of panning were performed against C. jejuni flagella as described previously (Arbabi-Ghahroudi et al., 2009a) . Briefly, wells of a 96-well Maxisorp TM plate (Nunc, Rochester, NY) were coated with 15 mg of flagella or PBS (as a blank) overnight at 48C. The wells were rinsed with PBS and blocked with PBS/1% (w/v) casein for 2 h at 378C. Mixed protease-treated phage particles (100 ml) were added to the blocked wells and incubated for 2 h at 378C. The wells were washed six times with PBST (PBS with 0.1% (v/v) Tween-20) and six times with PBS. The bound phage were eluted with 0.1 M triethylamine, neutralized with 1 M TrisHCl, pH 7.4, and incubated with exponentially growing E. coli TG1 cells. After 30 min of incubation at 378C, the cells were superinfected with M13KO7 helper phage for an additional 15 min and grown in 2xYT/ampicillin/kanamycin overnight at 378C. Amplified phage were purified and panning was continued for three more rounds following the same conditions, except that phage-protease digestion conditions were changed as described above, the antigen concentration was reduced to 12.5, 10 and 10 mg/well and washing was increased to 7, 10 and 12Â with PBST and 7, 10 and 12Â with PBS for the second, third and fourth rounds of panning, respectively. After four rounds of panning, 24 randomly picked colonies were subjected to colony PCR and the PCR fragments were sequenced. A total of nine flagella-specific V H Hs (F1, F3, F7, F10, F13, F14, F20, F22 and F23) with one to four nucleotide point mutations were identified. The mutant clones along with the parental V1 clone were grown and subjected to phage enzyme-linked immunosorbent assay (ELISA) screening as described previously (Arbabi-Ghahroudi et al., 2009a) , except that 5 mg/ml of flagella was coated onto microtiter plates. Only the F7, F13, F20 and F23 clones showed positive signals and were selected for further characterization.
Expression and purification of soluble V H Hs
Genes encoding mutant V H Hs obtained from panning the errorprone PCR library against C. jejuni flagella were PCR-amplified from the pMED6 phagemid vector with BbsI1-V H H and BamHI-V H H primers (Table I ). These PCR fragments were digested with BbsI and BamHI restriction endonucleases and ligated into the similarly digested pSJF2H expression vector (Arbabi-Ghahroudi et al., 2009a) . Upon ligation, all plasmids were transformed into electrocompetent E. coli TG1 and selected on LB agar plates containing ampicillin. Colonies were screened by colony PCR for inserts and the DNA sequenced. Small-scale expression was performed on individual clones and Table I . Oligonucleotides used in this study.
Name
Sequence (5 0 !3 0 ) Purpose
only clone F23 was found to have an expression level comparable with that of the parental V1 clone. V H Hs V1 and F23 were expressed using a 5 day minimal media method (Baral and Arbabi-Ghahroudi, 2012) . After induction of protein expression, cell cultures were harvested at 6000Âg (30 min, 48C), the supernatant discarded and the periplasmic contents extracted from the cell pellet. Briefly, cell pellets containing V H Hs were resuspended in 20 ml of ice-cold TES (0.2 M Tris -HCl, pH 8.0, 20% (w/v) sucrose, 0.5 mM EDTA) and incubated on ice for 30 min. Next, 30 ml of ice-cold 1/8 TES was added, the mixture was incubated for an additional 30 min on ice, and the slurry centrifuged at 8000Âg (30 min, 48C). The resulting supernatant containing V H H was dialyzed overnight into buffer A (10 mM HEPES, pH 7.0, 500 mM NaCl) and V H Hs were purified by immobilized metal-ion affinity chromatography (IMAC) as described (Arbabi-Ghahroudi et al., 2009a) . Eluted fractions were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS -PAGE) and Western blotting (data not shown) before being dialyzed into PBS. V H H concentrations were determined by absorbance measurements at 280 nm using theoretical molecular mass and extinction coefficients calculated with the ExPASy ProtParam Tool (http://expasy.org/tools/ protparam.html) (Pace et al., 1995) .
Construction of disulfide-bond V H H variants
Cysteine mutations were introduced at positions 54 and 78 of V1 and F23 V H Hs, for the generation of a non-canonical disulfide bond, using splice-overlap extension PCR essentially as described (Hussack et al., 2011) . To create the V1-DSB V H H, which contains two disulfide bonds, the overlap PCR extension fragments were amplified using BbsI1-V H H/V1-DSB-rev and V1-DSB-for/BamHI-V H H primer sets (Table I) . Likewise, the F23-DSB V H H was created by amplifying the DNA encoding F23 with F23-DSB-for/V1-DSB-rev and V1-DSB-for/BamHI-V H H primer sets (Table I ). All DNA constructs were cloned into the pSJF2H expression vector, transformed into E. coli TG1 and expressed/purified as described for V1 and F23.
Size-exclusion chromatography and surface plasmon resonance analyses
Size-exclusion chromatography (SEC) was performed prior to surface plasmon resonance (SPR) analysis using a Superdex TM 75 column and 50 mM of V H H, as described previously (Hussack et al., 2011) . Chromatograms were normalized as described previously (Kim et al., 2012) . Prior to SPR analysis on a Biacore 3000 (GE Healthcare, Baie-d'Urfé, QC, Canada), flagella from C. jejuni strain 81-176 was isolated (Riazi et al., 2013) , and biotinylated using a EZ-Link Sulfo-NHSBiotinylation kit according to the manufacturer's instructions (Fisher Scientific, Ottawa, ON, Canada). Uncoupled biotin was removed by dialysis against 1000Â volume of PBS for a total of eight times. For binding analysis, 2000 resonance units (RUs) of biotinylated flagella were immobilized onto a CAP sensor chip (GE Healthcare) previously loaded with the biotin CAPture reagent (50 mg/ml in HBS-EP buffer; GE Healthcare). Monomeric V H Hs eluted from the SEC column were injected over the immobilized flagella at concentrations ranging from 25-400 nM, using multiple injections of increasing concentrations and single-cycle kinetic analysis. The running buffer for all SPR experiments was HBS-EP (10 mM HEPES, 150 mM NaCl, 3 mM EDTA, pH 7.4, 0.005% surfactant P20; GE Healthcare). The surface was stripped after each V H H using regeneration buffers (8 M guanidine hydrochloride and 1 M NaOH) and a fresh biotinylated flagella surface was prepared as described above.
Thermal unfolding analysis of V H Hs
V H H T m s were determined by circular dichroism measurements at pH values 7.3 and 2.0 using a Jasco J-815 spectrometer (Jasco, Easton, MD) by following V H H unfolding at 215 nm, essentially as described (Hussack et al., 2011) . The only exception to the previously described protocol (Hussack et al., 2011) was that circular dichroism measurements were taken every 0.28C from 25 to 968C. In the case of V1 V H H, 10 mg/ ml was used for T m determination at pH 7.3 because of aggregation at high temperatures using 50 mg/ml.
In vitro protease digestions of V H Hs V H Hs were subjected to protease digestion assays with the major GI proteases pepsin (Sigma, Oakville, ON, Canada), sequencing-grade trypsin (Roche) and sequencing-grade chymotrypsin (Roche). V H H digestions were performed and quantified exactly as described (Hussack et al., 2011) and analyzed by SDS -PAGE thereafter. A total of three independent protease digestions were performed on each V H H and each of these independent digestions was performed in duplicates.
In addition to individual protease digestions, a sequential digestion reaction was performed in which V H Hs (50 mg) were first digested with pepsin (10 mg/ml, 378C, pH 2.0) for 15 or 30 min, followed by digestion with trypsin þ chymotrypsin (10 mg/ml for each, 378C, pH 7.4) for 15 or 30 min, in a total volume of 50 ml. After the pepsin digestion, the pH of the reaction was neutralized with 1 M NaOH to stop the reaction. After the trypsin þ chymotrypsin digestion, protease inhibitor cocktail (Sigma) was added to stop the reaction. Sequentially digested V H Hs were compared with non-treated controls by SDS-PAGE and analyzed for functionality in a C. jejuni motility assay (see below).
Campylobacter jejuni motility assay
Campylobacter jejuni motility assays were performed as described previously (Kalmokoff et al., 2006) . V H Hs, at a final concentration of 1 mg/ml, were incubated with C. jejuni (5 Â 10 4 colony-forming units) at room temperature for 30 min. The mixtures were plated, as described in Waseh et al. (2010) , in the center of a Petri dish containing Müller -Hinton agar (0.4%) and incubated at 378C under microaerobic conditions (5% O 2 , 10% CO 2 and 85% N 2 ). Bacterial motility was determined by measuring the diameter of the circle produced by the growing bacteria at 24 h after plating the bacteria.
Results
Construction of the mutant V1 library by error-prone PCR and protease panning
The V H H FlagV1M (referred to as 'V1' in this work) was isolated from a phage-displayed immune llama library against C. jejuni flagella (Riazi et al., 2013) . Before construction of a V1 error-prone PCR library to select for protease-resistant variants, we removed the His 6 /HA tags from the pMED1 phagemid vector (Arbabi-Ghahroudi et al., 2009b), generating pMED6 (Fig. 1A) . The His 6 /HA tags were previously shown to be sensitive to proteolytic cleavage (data not shown). The new pMED6 phagemid vector contained an amber stop codon 4 nucleotides downstream of the 5 0 SfiI restriction endonuclease site where the previous His 6 /HA tag was located. We adopted an error-prone PCR method (Leung et al., 1989; Stemmer, 1994) to introduce random mutations with the purpose of isolating protease-resistant mutants. A similar method has been successfully used for affinity maturation of conventional IgG antibodies as well as scFvs and V NAR s (Miyazaki et al., 1999; Daugherty et al., 2000; Nuttall et al., 2004; Fennell et al., 2010) . For library construction, random mutations were introduced into the V1 V H H gene by errorprone PCR and the amplified PCR products were used to construct the mutant library with an approximate size of 2 Â 10 9 transformants. Sequencing data from randomly selected colonies demonstrated the presence of point mutations within the V H H amino acid sequence at the rate of three to five nucleotide substitutions per V H H gene (data not shown). For panning, and in order to select V H Hs resisting the chicken GI tract environment, the rescued phage antibodies were pre-incubated with either chicken GI tract fluids harboring various proteases or the major GI proteases pepsin, trypsin and chymotrypsin (Fig. 1B) . The filamentous phages (f1, fd and M13) are known to be resistant to most GI tract fluid proteases (Schwind et al., 1992) and phage display, therefore, is a feasible display platform to select protease-resistant V H Hs. After panning, nine different V H Hs were isolated with two to four amino acid mutations in their framework region 1 (FR1), FR2, CDR2 and FR3 and around half of these clones (F7, F13, F20 and F23) turned out to be positive binders for C. jejuni flagella as determined by phage ELISA (Fig. 1C and D) . All clones possessed a Lys3!Gln3 substitution and a Glu5!Val5 substitution (IMGT numbering system, http://www.imgt.org/). The CDRs of all variants were identical to the parent V1 V H H with the exception of V H H F3 which possessed an Arg!Gly substitution in CDR2. The consistent substitution of Lys with Gln and Arg with Gly is in agreement with the fact that trypsin digests peptide bonds after basic amino acids such as lysine and arginine. While several potential protease-resistant V H Hs were identified, the F23 V H H had a comparable expression level to the parent V1 and showed the highest level of resistance to trypsin treatment among the V H Hs isolated in the screen. Therefore, the V H H F23 clone was chosen for expression and further binding and stability analysis.
Construction of disulfide-engineered variant V H Hs and SEC analysis
In addition to the parental V1 V H H and the F23 V H H, which was isolated form protease panning of the error-prone PCR library, an engineered variant of each V H H was produced with a second disulfide bond by mutating Ala54 and Ile78 to Cys54 and Cys78, giving V1-DSB and F23-DSB ( Fig. 2A and B) . All V H Hs were expressed and purified by IMAC and shown to be pure by SDS-PAGE (Fig. 2C) . All ran at their expected molecular masses and there were no signs of higher-order multimers on the non-reducing SDS-PAGE gel. V H H expression yields ranged from 9.5 mg (V1-DSB) to 21 mg (F23) per liter of bacterial culture (Table II) , which is consistent with our previous findings that the Cys54-Cys78 disulfide bond compromises V H H expression (Hussack et al., 2011) . SEC chromatograms suggested that all of the V H Hs were monomeric (Fig. 2E) . Intact mass and fingerprinting analysis was not performed to confirm the formation of the Cys54-Cys78 disulfide bond within the engineered variants (Hussack et al., 2011) ; however, the significant increase in V H H T m s (see below) and reduction in yields strongly suggest the introduced disulfide bond was successfully formed, as shown before for several other V H H, V H and V L domains harboring the identical Cys54-Cys78 mutations (Hussack et al., 2011; Kim et al., 2012 Kim et al., , 2013 .
Binding and thermal unfolding analyses of V H Hs
The affinity of all 4 V H Hs was determined by SPR using single-cycle kinetics. The sensorgrams and affinities of V1, V1-DSB, F23 and F23-DSB are shown (Fig. 2D ) and reported in Table II Table II ). It should be noted that V1 V H H aggregated at temperatures .688C when tested at 50 mg/ml (Fig. 3, inset) ; however, when the concentration was reduced to 10 mg/ml, no aggregation was detectable at higher temperatures and a single-phase unfolding curve was obtained. The T m s of V H Hs were also determined at pH 2.0. Before performing unfolding experiments, V H Hs were incubated for 2 h at pH 2.0. At this pH, V1 was completely unfolded at the starting temperature (258C) and a T m could not be determined (Fig. 3) . V1-DSB on the other hand was folded at 258C at pH 2.0 and had a T m of 42.4 + 0.18C, illustrating the significant impact the second disulfide bond has on V1-DSB stability. F23 was partially unfolded at 258C at pH 2.0 and a T m of 30.5 + 0.38C was determined, an improvement from the parental V1 V H H which was completely unfolded under these conditions. This result underscores the success of the protease-panning strategy in selecting for more stable binders and with a higher T m . Similar to pH 7.3, the clone with the highest T m at pH 2.0 was F23-DSB, with a T m of 44.6 + 0.18C, suggesting that the effects of the stabilizing mutations in F23 and the effects of the second disulfide bond were partially additive to create the hyperstabilized F23-DSB V H H.
In vitro protease digestion of V H Hs
The resistance of V1, V1-DSB, F23 and F23-DSB to the major GI proteases was determined ( Fig. 4; Table II ). Both V1 and F23 V H Hs were susceptible to pepsin degradation, with 22.3 + 8.1 and 6.8 + 3.6% of V H Hs remaining intact after 60 min exposure to pepsin, respectively. The disulfide-engineered variants were considerably more resistant to pepsin, with V1-DSB 52.9 + 6.5 49.5 + 6.7 85.4 + 3.3 90.9 + 4.1 a 10 mg/ml of V H H used for circular dichroism due to the aggregation of V1 at 50 mg/ml. b Digestions performed using 100 mg/ml of protease. c Digestions performed using 10 mg/ml of protease. Nd: not determined since the protein denatured at pH 2.0, 258C; res., resistance.
Engineered VHHs inhibit C. jejuni motility showing complete resistance (100.5 + 6.7%) at a pepsin concentration of 100 mg/ml. F23-DSB was also very resistant to pepsin, with 96.9 + 15.8% of the V H H remaining intact after 60 min. When digested with trypsin for 60 min, F23 was completely resistant (101.1 + 4.7%) followed by V1 (84.4 + 1.8%), F23-DSB (49.1 + 15.4%) and V1-DSB (41.3 + 2.7%). It is obvious that the addition of the second disulfide bond between Cys54-Cys78 reduces trypsin resistance for both clones here, a result that is similar to previous findings for some C. difficile toxin A specific V H Hs (Hussack et al., 2011) . The significant reduction in trypsin resistance of F23-DSB suggests that structural changes in the V H H domain may lead to the exposure of trypsin-sensitive sites (i.e. Lys and Arg) upon the addition of the second disulfide bridge. When digested with chymotrypsin for 60 min, F23-DSB displayed the highest resistance (90.9 + 4.1%) followed by F23 (85.4 + 3.3%), V1 (52.9 + 6.5%) and V1-DSB (49.5 + 6.7%). Therefore, in the case of these V H Hs, the second disulfide bond does not affect chymotrypsin resistance but does decrease trypsin resistance. Collectively, these data suggest that the F23 variant isolated from protease-panning was selected for very high trypsin and chymotrypsin resistance, and that the strongest combined resistance for all three proteases is the F23-DSB variant.
Sequential protease treatment of V H Hs
To determine whether the two strategies used to isolate robust, hyperstabilized V H Hs were effective in a biological setting, we exposed all four V H Hs to a sequential protease digestion scheme reminiscent of the GI tract (Fig. 5A, upper panel) . Specifically, we treated V H Hs with pepsin at pH 2.0 followed by trypsin and chymotrypsin at pH 7.3 for 15 or 30 min each. Analysis of the sequential digestions and non-treated controls by SDS-PAGE is shown (Fig. 5A, lower panel) . Near complete digestion of V1 is evident at 15 and 30 min relative to control V1 (compare 'V1' with 'V1(15)' and 'V1(30)'). F23 was more resistant than V1, with a strong band representing intact V H H present after the sequential 15 min digest (compare 'F23' with 'F23(15)'). After 30 min, a near complete digestion of F23 was evident. Conversely, both disulfide-bond variants were strongly resistant to the sequential protease digestions, even after 30 min of treatment (compare 'V1-DSB' with 'V1-DSB(30)' and compare 'F23-DSB' with 'F23-DSB(30)'). Densitometry analysis of the bands revealed 74.5% of F23-DSB V H H intact after the sequential 30 min digest compared with 47.6% of V1-DSB V H H intact after the same treatment.
Campylobacter jejuni motility assays
Finally, we tested the C. jejuni motility inhibiting capacity of the V H H variants. All V H Hs were effective in inhibiting the growth and spread of C. jejuni after incubation for 24 h, with essentially the same efficacy ( Fig. 5B and C) . We then used the sequential protease-treated V H Hs (Fig. 5A ) in the same motility assay to confirm the disulfide-bond variant V H Hs retained their functionality. The protease-treated V1 and F23 V H Hs were almost entirely degraded after 15 or 30 min incubation conditions, and as expected, did not inhibit motility. On the other hand, the growth inhibiting activity of V1-DSB and F23-DSB mutants was basically unaffected by the protease treatment, further confirming that the protease-treated V H Hs remain largely intact (Fig. 5A ) and active in settings reminiscent of the GI tract.
Discussion
In this study, we report the generation of a hyperstabilized V H H against C. jejuni flagella with high thermal and proteolytic stability. This was achieved by combining an error-prone PCR approach and panning under protease pressure with the introduction of cysteine residues at two positions in V H H FRs. The hyperstable V H H mutant F23-DSB outperformed the parental V1 V H H in terms of resistance to proteases, while it maintained the motility-inhibitory properties and affinity of the parent V H H. The evolutionary approach used in this study had dual beneficial effects: (i) it helped to isolate a V H H with consistent mutations at residues at or near potential trypsin-sensitive sites (Lys3!Gln3; Glu5!Val5) and resulted in the F23 V H H variant with complete resistance to trypsin up to 60 min; and (ii) the isolated F23 V H H had an increased T m ( 118C greater than V1), while its production level in E. coli and antigenbinding affinity were similar to the V1 V H H. These findings show that certain amino acid combinations at positions 3 and 5 in the FR1 region may lead to a V H H scaffold with increased stability and moderate-to-complete resistance to key GI tract proteases, in particular, to trypsin. Previous studies on the V H domain of an anti-b-lactam murine scFv have shown that mutations in FR1, in particular at positions 6, 7 and 10, which may occur by the primer mixture used for the cloning of antibody gene, can have severe consequences on the folding yields and stabilities of antibodies (Jung et al., 2001) .
The introduction of cysteine residues at positions 54 and 78 formed a disulfide bridge that lead to increased stability, as previously shown for a panel of V H Hs, V H s and V L s (Hussack et al., 2011; Kim et al., 2012 Kim et al., , 2013 , and led to the generation of the hyperstable V H H F23-DSB. However, the addition of a second disulfide bond leads to minor structural changes when introduced into the F23 V H H scaffold, as evidenced by the lowered trypsin resistance of F23-DSB, leading to the speculation that one or more potential trypsin cleavage sites in FRs (namely, R18, R19, K43, R45, K64 and K86) are more accessible for proteolytic digestion. This is consistent with our previous work on other V H Hs (Hussack et al., 2011) . While it is obvious that the second disulfide bond leads to structural changes, these changes must be minor, and possibly restricted to influencing the framework regions only, because the antigen binding affinity of both V H Hs containing the second disulfide bond were nearly identical to that of the parental scaffolds. In the future, strategies to increase the trypsin resistant properties of F23-DSB could include the replacement of the framework residues noted above and other trypsin-sensitive residues (Frenken et al., 1993) by site-specific mutations or re-applying the errorprone PCR approach followed by panning under protease pressure against the same target antigen (as shown in this study).
The antibody engineering approach used here produced robust binding agents with favorable biophysical properties. Currently, the protein-engineered F23-DSB V H H is being The dashed line at 5 mm represents the spotting diameter of C. jejuni on the plates. Statistical analysis was performed by one-way ANOVA followed by Dunnett's multiple comparison test, all relative to the control with no V H H (**P , 0.01).
Engineered VHHs inhibit C. jejuni motility studied for the prevention or significant reduction of C. jejuni colonization in the chicken GI tract.
